Literature DB >> 21539985

Ranibizumab for retinal neovascularization.

Rodrigo Jorge, Rodrigo S Oliveira, Andre Messias, Felipe P Almeida, Mario L Strambe, Rogério A Costa, Ingrid U Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21539985     DOI： 10.1016/j.ophtha.2010.12.025

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  3 in total

1.  Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Authors:  André Messias; José Afonso Ramos Filho; Katharina Messias; Felipe P P Almeida; Rogério A Costa; Ingrid U Scott; Florian Gekeler; Rodrigo Jorge
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

2.  Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.

Authors:  Nikhlesh K Singh; Dale E Hansen; Venkatesh Kundumani-Sridharan; Gadiparthi N Rao
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

3.  Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas-A randomized study.

Authors:  Luiza Toscano; Andre Messias; Katharina Messias; Rafaella de Cenço Lopes; Jefferson A Santana Ribeiro; Ingrid U Scott; Rodrigo Jorge
Journal:  Doc Ophthalmol       Date:  2021-08-04       Impact factor: 2.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.